PepTivator EBV LMP2A, human, 60 nmol
货号：
130-093-616 基本售价：
询价 规格：
EA
产品信息
概述| 货号 | 130-093-616 |
| 描述 | PepTivator® EBV LMP2A is a pool of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap, covering the sequence of the Epstein-Barr virus LMP2A protein (UniProt ID: P13285).PepTivator peptide pools have been developed for the efficient stimulation of CD4+ and CD8+ T cells, as peptides of 15 aa length and 11 aa overlap represent the optimal solution for stimulating both, CD4+ and CD8+ T cells in various applications.Quantitative, phenotypical, or functional analysis of EBV LMP2A–specific T cell immunity can provide important information on the natural course of immune responses in healthy or immunocompromised individuals.PepTivator EBV LMP2A-HT is a peptide pool lyophilized in the wells of a 96-well plate, allowing stimulation and analysis of cells directly on the plate. The convenient 96-well format, composed of 12 individually removable strips of 8 wells each allows for easy and flexible experimental set-up, different antigens can be combined by assembling different strips. A control can also be added easily by using strips from the Control plate (12x8). |
性能| 供应商 | Miltenyi |
| 背景 | Epstein-Barr virus (EBV) is a human γ-herpesvirus with B cell growth–transforming ability and lymphomagenic potential. More than 90% of human adults are infected with EBV. In healthy individuals, EBV typically establishes a persistent latent infection, in which the virus can be detected in resting, non-proliferating peripheral B lymphocytes. Expression of the viral protein latent membrane protein 2A (LMP2A) maintains the latency phase. |
